Peritoneal Dialysis Daily Versus Six Days Per Week

Peritoneal Dialysis Clinical Trial

Official title: Peritoneal Dialysis Daily Versus Six Days Per Week

Status Not yet recruiting

Clinical Trial Summary

The study will enroll patients receiving daily peritoneal dialysis who have significant residual native kidney function. The investiators will visit the patients at a routinely scheduled clinic visit and again at a non-routine visit after the patients skip a single day of dialysis. Blood samples will be obtained and a quality of life questionnaire will be administered at both visits. The primary aim will be to determine whether the patients would prefer daily treatment or being allowed to skip one day per week. Other aims will be to determine the effect of skipping a day on plasma levels of urea nitrogen and creatinine.

Clinical Trial Description

The patients' preference will be assessed by asking the simple question would you prefer to perform peritoneal dialysis daily of six days per week. The quality of life questionnaire to be used will be the Dialysis Symptom Index (DSI) which has a range of 0 to 150 with a high score reflecting worse quality of life. The chemical to be measured will be the plasma urea nitrogen in mg/dl and the plasma creatinine in mg/dl as measured by the clinical laboratory. ;

Related Conditions & MeSH terms

• Peritoneal Dialysis

• NCT number: NCT06399848
• Study type: Interventional
• Source: Stanford University
• Contact: Timothy W Meyer, MD
• Phone: 650-852-3314
• Email: twmeyer@stanford.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2024
• Completion date: June 2025